SEER Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 16:00):

Stats
Today's Volume	1.54M
Average Volume	478 267
Market Cap	117.24M
EPS	$0 ( 2024-02-29 )
Next earnings date	( $-0.310 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.340
ATR14	$0.00400 (0.22%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-07	Farokhzad Omid	Sell	52 857	Class A Common Stock
2024-02-06	Kogan Elona	Buy	123 153	Class A Common Stock
2024-02-22	Kogan Elona	Sell	12 684	Class A Common Stock
2024-02-06	Kogan Elona	Buy	140 000	Employee Stock Option (right to buy)
2024-02-06	Kogan Elona	Buy	79 729	Employee Stock Option (right to buy)

INSIDER POWER
86.08
Last 98 transactions
Buy: 6 813 760 \| Sell: 922 350

Volume Correlation

Long: -0.15 (neutral)

Short: -0.24 (neutral)

Signal:(51.4) Neutral

Seer, Inc. Correlation

10 Most Positive Correlations
GXGX	0.92
CRON	0.911
NVTSW	0.908
IRBT	0.908
EVLO	0.906
CREG	0.903
SWAV	0.902
EPSN	0.899
HOL	0.898
BCAB	0.897

10 Most Negative Correlations
BRIV	-0.911
PATK	-0.908
ALXN	-0.907
APMI	-0.906
GMFI	-0.905
ENTF	-0.905
CBRG	-0.904
ACAB	-0.903
ENER	-0.903
EMLD	-0.903

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Seer, Inc. Correlation - Currency/Commodity

0.69
( moderate )

0.78
( moderate )

0.00
( neutral )

0.73
( moderate )

0.00
( neutral )

-0.88
( strong negative )

Seer, Inc. Financials

Annual	2023
Revenue:	$15.18M
Gross Profit:	$1.45M (9.54 %)
EPS:	$-1.350

Q4	2023
Revenue:	$4.18M
Gross Profit:	$162 999 (3.90 %)
EPS:	$-0.280

Q3	2023
Revenue:	$3.81M
Gross Profit:	$1.81M (47.40 %)
EPS:	$-0.330

Q2	2023
Revenue:	$3.47M
Gross Profit:	$1.74M (50.23 %)
EPS:	$-0.370

Financial Reports:

No articles found.

Seer, Inc.

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.